These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
914 related articles for article (PubMed ID: 32631382)
1. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382 [TBL] [Abstract][Full Text] [Related]
2. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma. Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827 [TBL] [Abstract][Full Text] [Related]
4. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice. Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543 [TBL] [Abstract][Full Text] [Related]
5. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527 [TBL] [Abstract][Full Text] [Related]
6. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation. Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973 [TBL] [Abstract][Full Text] [Related]
7. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Huang M; Xiong H; Luo D; Xu B; Liu H Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125 [TBL] [Abstract][Full Text] [Related]
8. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway. Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H Molecules; 2019 May; 24(10):. PubMed ID: 31137633 [TBL] [Abstract][Full Text] [Related]
9. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway. Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101 [TBL] [Abstract][Full Text] [Related]
10. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma. Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438 [TBL] [Abstract][Full Text] [Related]
11. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity. Fei M; Li X; Liang S; Zhou S; Wu H; Sun L; Liu Y; Hu Q; Liu L; Wang J Cancer Lett; 2024 Mar; 584():216620. PubMed ID: 38218456 [TBL] [Abstract][Full Text] [Related]
12. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect. Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591 [TBL] [Abstract][Full Text] [Related]
13. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523 [TBL] [Abstract][Full Text] [Related]
14. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555 [TBL] [Abstract][Full Text] [Related]
15. Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling. Chen L; Lin X; Lei Y; Xu X; Zhou Q; Chen Y; Liu H; Jiang J; Yang Y; Zheng F; Wu B J Exp Clin Cancer Res; 2022 Nov; 41(1):329. PubMed ID: 36411480 [TBL] [Abstract][Full Text] [Related]
16. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation. Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916 [TBL] [Abstract][Full Text] [Related]
17. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
18. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis. Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164 [TBL] [Abstract][Full Text] [Related]
19. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Lin YH; Wu MH; Huang YH; Yeh CT; Cheng ML; Chi HC; Tsai CY; Chung IH; Chen CY; Lin KH Hepatology; 2018 Jan; 67(1):188-203. PubMed ID: 28802060 [TBL] [Abstract][Full Text] [Related]
20. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]